A rate-limiting enzyme in BCAA catabolism, named BCKDK, has also been reported to promote colorectal cancer tumorigenesis via upregulating the MAPK pathway by phosphorylating MEK at Ser221 (Xue et al., 2017). This evidence concerns the gene BCKDK and colorectal cancer.